Search Images Maps Play YouTube News Gmail Drive More »
Advanced Patent Search | Web History | Sign in

Patents

Referenced by

Citing PatentFiling dateIssue dateOriginal AssigneeTitle
US39516224 Dec 197420 Apr 1976Time release perfume method and device
US396015015 Sep 19751 Jun 1976Alza CorporationBioerodible ocular device
US396162821 Apr 19758 Jun 1976Alza CorporationOcular drug dispensing system
US397299514 Apr 19753 Aug 1976American Home Products CorporationDosage form
US398130331 Jul 197521 Sep 1976Alza CorporationBioerodible ocular device
US39865101 Aug 197519 Oct 1976Alza CorporationBioerodible ocular device
US399307124 Jul 197523 Nov 1976Alza CorporationBioerodible ocular device
US39930733 Mar 197523 Nov 1976Alza CorporationNovel drug delivery device
US39969349 Aug 197114 Dec 1976Alza CorporationMedical bandage
US402629018 Nov 197531 May 1977Fisons LimitedMethod of administering medicaments through the skin
US40318947 Sep 197628 Jun 1977Alza CorporationBandage for transdermally administering scopolamine to prevent nausea
US403965321 Jul 19752 Aug 1977DeFoney, Brenman, Mayes & BaronLong-acting articles for oral delivery and process
US418674328 Feb 19785 Feb 1980Personal Products CompanyPerfuming self-adhering napkins
US421063320 Oct 19781 Jul 1980Eli Lilly and CompanyFlurandrenolide film formulation
US429101411 Jul 198022 Sep 1981Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing estradiol diacetate
US429101526 Jun 198022 Sep 1981Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing a vasodilator
US42923019 Jul 198029 Sep 1981Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing ephedrine
US42923029 Jul 198029 Sep 1981Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing terbutaline
US42923039 Jul 198029 Sep 1981Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing clonidine
US42948209 Jul 198013 Oct 1981Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing phenylephrine
US431050931 Jul 197912 Jan 1982Minnesota Mining and Manufacturing CompanyPressure-sensitive adhesive having a broad spectrum antimicrobial therein
US432125217 Dec 198023 Mar 1982Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing ester derivatives of estradiol
US432355731 Jul 19796 Apr 1982Minnesota Mining & Manufacturing CompanyPressure-sensitive adhesive containing iodine
US432933324 Nov 198011 May 1982Method for the oral treatment of dogs and other animals
US43362434 May 198122 Jun 1982G. D. Searle & Co.Transdermal nitroglycerin pad
US434004317 Jul 198020 Jul 1982Smith & Nephew Research Ltd.Adhesive-coated sheet material incorporating anti-bacterial substances
US440920614 Aug 198111 Oct 1983Boehringer Ingelheim GmbHTransdermal release system for pharmaceutical preparation
US44551462 Mar 198219 Jun 1984Hisamitsu Pharmaceutical Co., Ltd.Novel plasters
US446036921 Dec 198117 Jul 1984Smith & Nephew Research Ltd.Adhesive-coated sheet material incorporating anti-bacterial substances
US446056230 Mar 198317 Jul 1984Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing propranolol
US449268530 Jan 19848 Jan 1985Key Pharmaceuticals, Inc.Protective skin matrix
US456318417 Oct 19837 Jan 1986Synthetic resin wound dressing and method of treatment using same
US456401018 Apr 198414 Jan 1986Daubert Coated Products Inc.Pressure sensitive adhesive film for medical use
US45683439 Oct 19844 Feb 1986Alza CorporationSkin permeation enhancer compositions
US459796123 Jan 19851 Jul 1986Transcutaneous application of nicotine
US461478713 Nov 198430 Sep 1986Thermedics, Inc.Drug dispensing wound dressing
US46312275 Dec 198323 Dec 1986Toilet article
US463804323 Aug 198520 Jan 1987Thermedics, Inc.Drug release system
US466644117 Dec 198519 May 1987Ciba-Geigy CorporationMulticompartmentalized transdermal patches
US466703210 Oct 198519 May 1987Merck Frosst Canada, Inc.Phenothiazone derivatives and analogs
US46906832 Jul 19851 Sep 1987Rutgers, the State University of New JerseyTransdermal varapamil delivery device
US471922631 Dec 198412 Jan 1988Nitto Electric Industrial Co., Ltd.Percutaneous absorption type preparation and process for preparing the same
US472786820 May 19871 Mar 1988Thermedics, Inc.Anisotropic wound dressing
US47388484 Jun 198619 Apr 1988Nitto Electric Industrial Co., Ltd.
Ikeda Mohando Co., Ltd.
Anti-inflammatory analgesic adhesive preparation
US474324910 Jun 198710 May 1988Ciba-Geigy Corp.Dermal and transdermal patches having a discontinuous pattern adhesive layer
US474651526 Feb 198724 May 1988ALZA CorporationSkin permeation enhancer compositions using glycerol monolaurate
US475113311 May 198714 Jun 1988Thermedics, Inc.Medical patches and processes for producing same
US475538415 Mar 19845 Jul 1988Kozponti Valto- es Hitelbank RT, Innovacious AlapExternally applied antispasmatic products
US476436222 Oct 198616 Aug 1988The Cook Bates CompanyNail-conditioning emery boards and process for making them
US476437924 Aug 198716 Aug 1988Alza CorporationTransdermal drug delivery device with dual permeation enhancers
US47770461 Oct 198511 Oct 1988Nippon Kayaku Kabushiki Kaisha
Teikoku Seiyaku Kabushiki Kaisha
Kaken Pharmaceutical Co., Ltd.
Sheet-like preparation
US47819249 Nov 19871 Nov 1988ALZA CorporationTransdermal drug delivery device
US478806226 Feb 198729 Nov 1988ALZA CorporationTransdermal administration of progesterone, estradiol esters, and mixtures thereof
US48123059 Nov 198714 Mar 1989Well medicine strip
US48139767 Apr 198821 Mar 1989The Cook Bates CompanyNail-conditioning emery boards and process for making them
US481625826 Feb 198728 Mar 1989ALZA CorporationTransdermal contraceptive formulations
US482072029 Mar 198811 Apr 1989ALZA CorporationTransdermal drug composition with dual permeation enhancers
US483497914 Dec 198730 May 1989ALZA CorporationMedical bandage for administering beneficial drug
US48370279 Aug 19886 Jun 1989ALZA CorporationTransdermal drug delivery device
US48391745 Oct 198713 Jun 1989Pharmetrix CorporationNovel transdermal nicotine patch
US485966714 Jan 198722 Aug 1989Merck Frosst Canada, Inc.Pharmaceutical compositions of phenothiazone derivatives and analogs
US486373823 Nov 19875 Sep 1989ALZA CorporationSkin permeation enhancer compositions using glycerol monooleate
US486584826 Feb 198712 Sep 1989ALZA CorporationSkin permeation enhancer compositions using sucrose esters
US487927527 May 19887 Nov 1989Nelson Research & Development Co.Penetration enhancers for transdermal delivery of systemic agent
US48806909 Sep 198814 Nov 1989Thermedics, Inc.Perfume patch
US48851541 Mar 19885 Dec 1989Alza CorporationMethod for reducing sensitization or irritation in transdermal drug delivery and means therefor
US490647516 Feb 19886 Mar 1990Paco Pharmaceutical ServicesEstradiol transdermal delivery system
US490802712 Sep 198613 Mar 1990ALZA CorporationSubsaturated transdermal therapeutic system having improved release characteristics
US491768827 Jun 198817 Apr 1990Nelson Research & Development Co.Bandage for transdermal delivery of systemically-active drug
US491789514 Jul 198817 Apr 1990ALZA CorporationTransdermal drug delivery device
US492010130 Sep 198724 Apr 1990Nelson Research & Development Co.Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloaklkanes
US494058613 Oct 198810 Jul 1990Alza CorporationSkin permeation enhancer compositions using sucrose esters
US494343528 Oct 198824 Jul 1990Pharmetrix CorporationProlonged activity nicotine patch
US495617121 Jul 198911 Sep 1990Paco Pharmaceutical Services, Inc.Transdermal drug delivery using a dual permeation enhancer and method of performing the same
US495920828 Oct 198825 Sep 1990PPG Industries, Inc.Active agent delivery device
US496987115 Feb 198913 Nov 1990Alza CorporationIntravenous system for delivering a beneficial agent
US497346822 Mar 198927 Nov 1990Cygnus Research CorporationSkin permeation enhancer compositions
US498501615 Feb 198915 Jan 1991ALZA CorporationIntravenous system for delivering a beneficial agent
US50009568 Jul 198819 Mar 1991Alza CorporationPrevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
US500461014 Jun 19902 Apr 1991ALZA CorporationSubsaturated nicotine transdermal therapeutic system
US502655610 Nov 198825 Jun 1991Norwich Eaton Pharmaceuticals, Inc.Compositions for the transdermal delivery of pharmaceutical actives
US503438617 Aug 198823 Jul 1991Whitby Research, Inc.Methods for administration using 1-substituted azacycloalkanes
US503588610 May 199030 Jul 1991PPG Industries, Inc.Active agent delivery device
US504505915 Aug 19903 Sep 1991Alza CorporationIntravenous system for delivering a beneficial agent
US50493879 Jun 198917 Sep 1991Alza CorporationInducing skin tolerance to a sensitizing drug
US505322712 Jun 19901 Oct 1991Cygnus Therapeutic SystemsSkin permeation enhancer compositions, and methods and transdermal systems associated therewith
US50591898 Sep 198722 Oct 1991E. R. Squibb & Sons, Inc.Method of preparing adhesive dressings containing a pharmaceutically active ingredient
US505942612 Jun 199022 Oct 1991Cygnus Therapeutic SystemsSkin permeation enhancer compositions, and methods and transdermal systems associated therewith
US50611066 Nov 198929 Oct 1991Colgate-Palmolive CompanyToothbrush with slow release of disinfectant and antibacterial agents and method of manufacturing the same
US506822630 Apr 199026 Nov 1991Cyclex, Inc.Pharmaceutical preparations containing cyclodextrins and their use in iontophoretic therapies
US507164520 Mar 199110 Dec 1991PPG Industries, Inc.Process of producing an active agent delivery device
US507165731 Aug 199010 Dec 1991Schering AktiengesellschaftDevice for transdermal administration of active medicinal agents
US507705427 Nov 199031 Dec 1991Alza CorporationPrevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
US510489913 Aug 199014 Apr 1992Sepracor, Inc.Methods and compositions for treating depression using optically pure fluoxetine
US511850930 Aug 19912 Jun 1992ALZA CorporationInducing skin tolerance to a sensitizing drug
US51205453 Aug 19909 Jun 1992Alza CorporationReduction or prevention of sensitization to drugs
US512415718 Aug 198923 Jun 1992Cygnus Therapeutic Systems
Farmos Group Ltd.
Method and device for administering dexmedetomidine transdermally
US51301396 Jul 199014 Jul 1992Alza CorporationReduction or prevention of skin irritation by drugs
US513397011 Jul 199028 Jul 1992Rohm GmbH Chemische FabrikWater-soluble pressure-sensitive skin-adhesive and use thereof
US514953915 Nov 199122 Sep 1992ALZA CorporationReduction or prevention of sensitization to drugs
US516032012 Aug 19913 Nov 1992Alza CorporationIntravenous system for delivering a beneficial agent
US516074113 Nov 19913 Nov 1992ALZA CorporationReduction or prevention of skin irritation by drugs
US517157630 Aug 199115 Dec 1992ALZA CorporationPrevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
US517330228 Sep 199022 Dec 1992Medtronic, Inc.Hydrophilic pressure sensitive adhesive for topical administration of hydrophobic drugs
US518998623 Sep 19912 Mar 1993Alza CorporationVeterinary transdermal active agent delivery device
US51982239 Mar 199230 Mar 1993Alza CorporationTransdermal formulations, methods and devices
US520376824 Jul 199120 Apr 1993ALZA CorporationTransdermal delivery device
US52043396 Aug 199020 Apr 1993Whitby Research, Inc.Penetration enhancers for transdermal delivery of systemic agents
US521771817 Sep 19918 Jun 1993Cygnus Therapeutic Systems
Farmos Group Ltd.
Method and device for administering dexmedetomidine transdermally
US522326131 Dec 199129 Jun 1993Riker Laboratories, Inc.Transdermal estradiol delivery system
US522519924 Dec 19916 Jul 1993Teijin LimitedPharmaceutical plasters
US523469023 Aug 199110 Aug 1993Cygnus Therapeutic SystemsTransdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset
US52500289 Aug 19915 Oct 1993ALZA CorporationIntravenous system for delivering a beneficial agent using permeability enhancers
US526817914 Feb 19927 Dec 1993Ciba-Geigy CorporationUltrasonically sealed transdermal drug delivery systems
US527375523 Aug 199128 Dec 1993Cygnus Therapeutic SystemsTransdermal drug delivery device using a polymer-filled microporous membrane to achieve delayed onset
US527375623 Aug 199128 Dec 1993Cygnus Therapeutic SystemsTransdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset
US528466021 Aug 19928 Feb 1994Alza CorporationDelayed onset transdermal delivery device
US528649118 May 199215 Feb 1994Alza CorporationPrevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
US53043793 Nov 199219 Apr 1994Alza CorporationMethod for reducing sensitization or irritation in transdermal drug delivery and means therefor
US531469426 Mar 199324 May 1994Alza CorporationTransdermal formulations, methods and devices
US532085012 Feb 199314 Jun 1994ALZA CorporationTransdermal delivery of the gestogen ST-1435 and devices therefor
US534262318 Jun 199330 Aug 1994Alza CorporationSubsaturated transdermal therapeutic system having improved release characteristics
US53646348 Nov 199115 Nov 1994Southwest Research InstituteControlled-release PH sensitive capsule and adhesive system and method
US537637717 Dec 199227 Dec 1994ALZA CorporationTransdermal contraceptive formulations, methods and devices
US53787303 Dec 19923 Jan 1995Alza CorporationPermeation enhancer comprising ethanol and monoglycerides
US54027773 Jun 19924 Apr 1995ALZA CorporationMethods and devices for facilitated non-invasive oxygen monitoring
US541005420 Jul 199325 Apr 1995Merck Frosst Canada, Inc.Heteroaryl quinolines as inhibitors of leukotriene biosynthesis
US54117408 Feb 19942 May 1995ALZA CorporationTransdermal administration of oxybutynin
US542211821 Sep 19926 Jun 1995Pure Pac, Inc.Transdermal administration of amines with minimal irritation and high transdermal flux rate
US545140721 Jun 199319 Sep 1995ALZA CorporationReduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug
US546438727 Oct 19947 Nov 1995Alza CorporationTransdermal delivery device
US550022215 Feb 199519 Mar 1996Alza CorporationTransdermal administration of oxybutynin
US550803816 Apr 199016 Apr 1996Alza CorporationPolyisobutylene adhesives for transdermal devices
US550803913 Jun 199416 Apr 1996ALZA CorporationControlled transdermal administration of melatonin
US551229221 Dec 199430 Apr 1996ALZA CorporationTransdermal contraceptive formulations methods and devices
US558951115 Apr 199431 Dec 1996Sepracor Inc.Method for treating migraine headaches using optically pure S(+) fluoxetine
US563300812 Aug 199327 May 1997Method of administering nicotine transdermally
US563300912 Nov 199327 May 1997Sano CorporationTransdermal administration of azapirones
US564150421 Oct 199324 Jun 1997Alza CorporationSkin permeation enhancer compositions using glycerol monolinoleate
US56483967 Jun 199515 Jul 1997Sepracor Inc.Methods for treating depression and other disorders using optically pure R (-) fluoxetine and monoamine oxidase inhibitor
US566292821 Apr 19952 Sep 1997Ciba-Geigy CorporationMethod for the prevention or removal of crystalline scopolamine in a non-aqueous matrix of a transdermal system
US569137714 Jul 199425 Nov 1997University of Maryland Eastern Shore and University of Maryland College Park
The United States of America as represented by the Secretary of Agriculture
Use of N-methyl-aspartic acid for enhancing growth and altering body composition
US57004783 Aug 199523 Dec 1997Cygnus, Inc.Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavity
US570766316 May 199513 Jan 1998Alza CorporationSustained antiepileptic therapy
US570803522 May 199513 Jan 1998Sepracor Inc.
McLean Hospital
Methods of use and compositions of R(-) fluoxetine
US573325515 Oct 199631 Mar 1998Novartis Finance CorporationThermopile powered transdermal drug delivery device
US574706515 Mar 19965 May 1998Monoglyceride/lactate ester permeation enhancer for oxybutynin
US575013715 Mar 199612 May 1998Monoglyceride/lactate ester permeation enhancer
US57859917 Jun 199528 Jul 1998Alza CorporationSkin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US58173317 Jun 19956 Oct 1998Sano CorporationTransdermal administration of azapirones
US58208766 Jun 199513 Oct 1998LTS Lohmann Therapie-Systeme GmbH & Co. KGTransdermal therapeutic system
US58372807 Jun 199517 Nov 1998Sano CorporationTransdermal administration of azapirones
US584032715 Aug 199624 Nov 1998ALZA CorporationTransdermal drug delivery device having enhanced adhesion
US584346813 May 19961 Dec 1998ALZA CorporationSkin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US58826757 Mar 199716 Mar 1999Nitto Denko CorporationPercutaneous absorption preparation
US588267626 May 199516 Mar 1999Alza CorporationSkin permeation enhancer compositions using acyl lactylates
US589186821 Nov 19976 Apr 1999Kaiser Foundation Health Plan, Inc.
Permanente Medical Group, Inc.
The Regents of the University of California
Berlex Laboratories
Methods for treating postmenopausal women using ultra-low doses of estrogen
US590025030 Apr 19984 May 1999ALZA CorporationMonoglyceride/lactate ester permeation enhancer for oxybutnin
US591947814 Dec 19956 Jul 1999ALZA CorporationIncorporating poly-N-vinyl amide in a transdermal system
US593942628 Feb 199717 Aug 1999Sepracor Inc.Methods for treating urinary incontinence using descarboethoxyloratadine
US59624646 Jul 19985 Oct 1999Sepracor Inc.Methods and compositions for treating allergic asthma using descarboethoxyloratadine
US598094321 Oct 19979 Nov 1999Alza CorporationSustained antiepileptic therapy
US600139018 Dec 199614 Dec 1999Alza CorporationFormulations for transdermal delivery of pergolide
US600457823 Oct 199721 Dec 1999ALZA CorporationPermeation enhances for transdermal drug delivery compositions, devices and methods
US60078373 Feb 199928 Dec 1999Alza CorporationDrug delivery devices and process of manufacture
US605446317 Mar 199925 Apr 2000Sepracor Inc.Methods for treating dermatitis using descarboethoxyloratadine
US61002747 Jul 19998 Aug 2000Schering Corporation8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
US61104886 Jun 199529 Aug 2000LTS Lohmann Therapie-Systeme GmbH & Co. KGTransdermal therapeutic system, its use and production process
US611049920 Jul 199829 Aug 2000ALZA CorporationPhenytoin therapy
US611097328 Jan 199929 Aug 2000SepracorMethods for treating obesity and weight gain using optically pure (-)-bupropion
US611434622 Oct 19995 Sep 2000Schering CorporationTreating sleep disorders using desloratadine
US61269636 Jun 19953 Oct 2000LTS Lohmann Therapie-Systeme GmbH & Co. KGTransdermal therapeutic system, its use and production process
US61398686 Jun 199531 Oct 2000LTS Lohmann Therapie-Systeme GmbH & Co. KGTransdermal therapeutic system, its use and production process
US61654971 Mar 199126 Dec 2000ALZA CorporationSubsaturated nicotine transdermal therapeutic system
US61745453 Feb 199916 Jan 2001Alza CorporationDrug delivery devices and process of manufacture
US619068328 Aug 199720 Feb 2001Lintec CorporationBlackhead-removing face pack sheet
US619778827 Sep 19996 Mar 2001Vernalis Research Limited(-)-mefloquine to block puringergic receptors and to treat movement or neurodegenerative disorders
US62038175 Jun 199820 Mar 2001ALZA CorporationReduction of skin reactions caused by transdermal drug delivery
US62387005 May 199829 May 2001ALZA CorporationMethod for preventing crystal formation in a dispersion of a liquid in a matrix
US62654143 May 200024 Jul 2001Schering CorporationTreating sleep disorders using desloratadine
US626798417 Dec 199831 Jul 2001ALZA CorporationSkin permeation enhancer compositions comprising a monoglyceride and ethyl palmitate
US627788720 Apr 200021 Aug 2001Sepracor, Inc.Methods for treating Parkinson's disease using optically pure (-)-bupropion
US628759828 May 199311 Sep 2001Alza CorporationMethod for providing sustained antiepileptic therapy
US63127151 May 19986 Nov 20013M Innovative Properties CompanyAdhesive microsphere drug delivery composition
US633157111 Aug 199918 Dec 2001Sepracor, Inc.Methods of treating and preventing attention deficit disorders
US633732818 Aug 20008 Jan 2002Sepracor, Inc.Bupropion metabolites and methods of use
US633910614 Sep 200015 Jan 2002Sepracor, Inc.Methods and compositions for the treatment and prevention of sexual dysfunction
US634249622 Feb 200029 Jan 2002Sepracor Inc.Bupropion metabolites and methods of use
US634253330 Nov 199929 Jan 2002Sepracor, Inc.Derivatives of (
US634821010 Nov 199919 Feb 2002Alza CorporationMethods for transdermal drug administration
US636911327 Jun 20019 Apr 2002Sepracor, Inc.Method for treating depression using optically pure (
US639982611 Jan 20004 Jun 2002Sepracor Inc.Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
US641005210 Aug 200025 Jun 2002Purdue Research Foundation
Pharmanex, Inc.
Tea catechins in sustained release formulations as cancer specific proliferation inhibitors
US642881817 Aug 20006 Aug 2002Purdue Research Foundation
Pharmanex, Inc.
Tea catechin formulations and processes for making same
US64324461 Feb 200113 Aug 2002Bridge Pharma, Inc.Non-arrhythmogenic metabolite of oxybutynin
US644045727 May 199327 Aug 2002Alza CorporationMethod of administering antidepressant dosage form
US645186019 Feb 200217 Sep 2002Sepracor, Inc.Methods for treating depression and other disorders using optically pure (
US645837428 Jan 19991 Oct 2002Sepracor, Inc.Methods and compositions for treating chronic disorders using optically pure (
US647607829 Jan 20015 Nov 2002Sepracor, Inc.Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US64790737 Oct 199612 Nov 20023M Innovative Properties CompanyPressure sensitive adhesive articles and methods for preparing same
US649560513 Mar 200117 Dec 2002Sepracor Inc.Methods and compositions for aiding in smoking cessation and for treating pain and other disorders using optically pure (
US651201014 Jul 199728 Jan 2003Alza CorporationFormulations for the administration of fluoxetine
US65380344 Dec 200125 Mar 2003Methods of treating or preventing weight gain, obesity, and related disorders
US654808229 Feb 200015 Apr 2003Sepracor Inc.Methods for treating apnea and apnea disorders using optically pure R(
US655918815 Sep 20006 May 2003Novartis AGMethod of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
US65623577 Jun 199913 May 2003Lintec CorporationBlackhead removing sheet and method for producing blackhead removing sheet
US656944817 Oct 199727 May 2003Alza CorporationMethod for preventing crystal formation in a dispersion of a liquid in a matrix
US65728797 Jun 19953 Jun 2003Alza CorporationFormulations for transdermal delivery of pergolide
US659289229 Aug 200015 Jul 2003Tepha, Inc.Flushable disposable polymeric products
US661088712 Apr 200226 Aug 2003Sepracor Inc.Methods of preparing didesmethylsibutramine and other sibutramine derivatives
US66491831 Nov 200118 Nov 2003Sepracor Inc.Methods for treating apnea and apnea disorders using optically pure R(
US666029529 Sep 19989 Dec 2003Alza CorporationTransdermal drug delivery device package with improved drug stability
US666439722 Nov 199916 Dec 2003Vernalis Research LimitedUse of (
US669949723 Jul 19992 Mar 2004Alza CorporationFormulations for the transdermal administration of fenoldopam
US670967619 Jun 200223 Mar 2004Schering CorporationExtended release oral dosage composition
US67100874 Jun 200223 Mar 2004Sepracor, Inc.Methods of treating or preventing neuropathic pain using sibutramine metabolites
US673421317 May 200211 May 2004Smithkline Beecham CorporationPharmaceutically active morpholinol
US67702959 Aug 20003 Aug 2004Pharmacia ABTherapeutic formulation for administering tolterodine with controlled release
US682520524 Sep 200330 Nov 2004Euro-Celtique S.A.N-substituted hydromorphones and the use thereof
US685582017 May 200215 Feb 2005SmithKline Beecham CorporationPharmaceutically active morpholinol
US685858923 Jul 200222 Feb 2005Pharmacy and Therapeutic Advisory Consultancy Pty LTDMethods of and compositions for potentiating the action of agents active on cell wall sites of the susceptible bacteria
US687871312 Dec 200212 Apr 2005Wockhardt LimitedGeneration triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US687874916 Jan 200312 Apr 2005Novartis AGMethod of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
US689418920 Aug 200317 May 2005Sepracor Inc.Methods of preparing didesmethylsibutramine and other sibutramine derivatives
US691147919 Aug 200228 Jun 2005Sepracor Inc.Methods of treating and preventing pain, anxiety, and incontinence using derivatives of (−)-venlafaxine
US69518733 Mar 20004 Oct 2005Pfizer Inc.Methods for treating age-related behavioral disorders in companion animals
US696496623 Apr 200215 Nov 2005Wockhardt LimitedGeneration triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US697483723 Oct 200213 Dec 2005Sepracor Inc.Compositions comprising sibutramine metabolites in combination with phosphodiesterase inhibitors
US697483823 Mar 200413 Dec 2005Sepracor Inc.Methods of treating or preventing pain using sibutramine metabolites
US697946319 Jun 200227 Dec 2005Schering CorporationStable extended release oral dosage composition
US699516829 May 20037 Feb 2006Euro-Celtique S.A.Triazaspiro compounds useful for treating or preventing pain
US699840017 May 200214 Feb 2006Smithkline Beecham CorporationPharmaceutically active morpholinol
US701184422 Nov 200214 Mar 2006Alza CorporationFormulations for the administration of fluoxetine
US701903017 Jul 200328 Mar 2006Celgene CorporationImmunotherapeutic agents
US703405928 Jun 200225 Apr 2006Sepracor Inc.Methods of using norfluoxetine
US706385918 Sep 200220 Jun 2006Noven Pharmaceuticals, Inc.Barrier film lined backing layer composition and method for topical administration of active agents
US707123425 Mar 20034 Jul 2006Sepracor Inc.Methods of treating or preventing erectile dysfunction
US707852630 May 200318 Jul 2006TransForm Pharmaceuticals, Inc.CIS-itraconazole crystalline forms and related processes, pharmaceutical compositions and methods
US709442220 Aug 200322 Aug 2006Acrux DDS PTY Ltd.Topical delivery of antifungal agents
US709820617 May 200229 Aug 2006SmithKline Beecham CorporationPharmaceutically active morpholinol
US710533327 Mar 200212 Sep 2006Deadreon CorporationNucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon
US711243014 May 200226 Sep 2006Dendreon CorporationNucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
US712570313 Mar 200224 Oct 2006Dendreon CorporationNucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon
US714169621 May 200428 Nov 2006Bridge Pharma, Inc.Smooth muscle spasmolytic agents
US716402331 Dec 200316 Jan 2007Wockhardt LimitedBenzoquinolizine-2-carboxylic acid arginine salt tetrahydrate
US71694098 Sep 200330 Jan 2007Alza CorporationMethod for preventing crystal formation in a dispersion of a liquid in a matrix
US717289220 Mar 20026 Feb 2007Dendreon CorporationNucleic acid molecules encoding serine protease CVSP14, the encoded polypeptides and methods based thereon
US71762187 Jan 200513 Feb 2007ARYx TherapeuticsStereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US718295311 Dec 200027 Feb 2007Celgene CorporationMethods and compositions for the prevention and treatment of atherosclerosis restenosis and related disorders
US718686321 May 20046 Mar 2007TransForm Pharmaceuticals, Inc.Sertraline compositions
US718974011 Apr 200313 Mar 2007Celgene CorporationMethods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes
US72054131 May 200317 Apr 2007TransForm Pharmaceuticals, Inc.Solvates and polymorphs of ritonavir and methods of making and using the same
US721158223 Nov 19991 May 2007Sepracor Inc.Methods for treating urticaria using descarboethoxyloratadine
US721468316 Mar 19988 May 2007Sepracor Inc.Compositions of descarboethoxyloratadine
US721468417 Nov 20048 May 2007Sepracor Inc.Methods for the treatment of allergic rhinitis
US722964018 Dec 200112 Jun 2007SmithKline Beecham p.l.c.Paroxetine controlled release compositions
US72591524 Jun 200121 Aug 2007Alfa Wasserman, Inc.Methods and compositions using sulodexide for the treatment of diabetic nephropathy
US727636420 Nov 20002 Oct 2007Dendreon CorporationNucleic acids encoding endotheliases, endotheliases and uses thereof
US728250923 Mar 200516 Oct 2007Aryx TherapeuticsStereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US729134718 Jan 20066 Nov 2007WyethSuccinate salt of O-desmethyl-venlafaxine
US73234796 Nov 200329 Jan 2008Celgene CorporationMethods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline
US732348024 May 200529 Jan 2008Metabolex, Inc.Substituted triazoles as modulators of PPAR and methods of their preparation
US732678731 Aug 20065 Feb 2008ARYx Therapeutics, Inc.Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders
US732976116 Nov 200412 Feb 2008Celgene CorporationSubstituted imides
US735173929 Apr 20051 Apr 2008Wellgen, Inc.
The Regents of the University of Minnesota
Rutgers, the State University of New Jersey
Bioactive compounds and methods of uses thereof
US73549486 Nov 20038 Apr 2008Celgene CorporationMethods for treatment of chronic uveitis using cyclopropyl-n-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide
US73582467 Apr 200515 Apr 2008WyethThioamide derivatives as progesterone receptor modulators
US73938624 Oct 20051 Jul 2008Celgene CorporationMethod using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
US739386316 Jan 20071 Jul 2008Celgene CorporationMethods of using N-{[2-(2,6-dioxo(3-piperidyl)-1,3-dioxoisoindolin-4-yl]methyl}cyclopropyl-carboxamide for the treatment and management of myelodysplastic syndromes
US739395720 Sep 20041 Jul 2008Wockhardt LimitedGeneration triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US740522316 Jan 200129 Jul 2008Schering CorporationTreating allergic and inflammatory conditions
US741406216 Jun 200519 Aug 2008Purdue Pharma L.P.Triazaspiro compounds useful for treating or preventing pain
US74389037 May 200421 Oct 2008NBTY, Inc.Methods and compositions that enhance bioavailability of coenzyme-Q10
US744610726 Aug 20044 Nov 2008Transform Pharmaceuticals, Inc.Crystalline forms of conazoles and methods of making and using the same
US74658003 Sep 200416 Dec 2008Celgene CorporationPolymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
US74683638 Apr 200523 Dec 2008Celgene CorporationMethods for treatment of cancers using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
US747043517 Nov 200330 Dec 2008Andrx Pharmaceuticals, LLCExtended release venlafaxine formulation
US75110717 Mar 200831 Mar 2009WyethThioamide derivatives as progesterone receptor modulators
US751446625 Apr 20057 Apr 2009WyethPurification of progesterone receptor modulators
US751458330 May 20037 Apr 2009Proteotech, Inc.Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
US751801731 Jan 200714 Apr 2009Idexx LaboratoriesFenicol compounds and methods synthesizing 2-trifluoroacetamido-3-substituted propiophenone compounds
US755392326 Oct 200730 Jun 2009Metabolix, Inc.Medical devices and applications of polyhydroxyalkanoate polymers
US757281220 Jan 200611 Aug 2009Therapeutic agents useful for treating pain
US758263519 Dec 20031 Sep 2009Therapeutic agents useful for treating pain
US759233512 Apr 200622 Sep 2009Ranbaxy Laboratories LimitedOxazolidinone derivatives as antimicrobials
US761209623 Apr 20043 Nov 2009Celgene CorporationMethods for treatment, modification and management of radiculopathy using 1-oxo-2-(2,6-dioxopiperidin-3yl)-4-aminoisoindoline
US76186493 Nov 200317 Nov 2009Schering CorporationExtended release oral dosage composition
US762213618 Jun 200424 Nov 2009ALZA CorporationTransparent transdermal nicotine delivery devices
US762603224 Apr 20081 Dec 2009Wockhardt LimitedGeneration triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US762946625 Apr 20088 Dec 2009ARYx Therapeutics, Inc.Synthetic methods and intermediates for steroisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders
US764182529 Jul 20055 Jan 2010Tepha, Inc.Method of making a polyhydroxyalkanoate filament
US76422875 Aug 20055 Jan 2010Transform Pharmaceuticals, Inc.Statin pharmaceutical compositions and related methods of treatment
US765926512 Feb 20099 Feb 2010WyethThioamide derivatives as progesterone receptor modulators
US765928212 Jan 20059 Feb 2010Avanir Pharmaceuticals, Inc.Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
US765928731 May 20079 Feb 2010Amgen Inc.Benzamide derivatives and uses related thereto
US767109327 May 20052 Mar 2010Transform Pharmaceuticals, Inc.Mixed co-crystals and pharmaceutical compositions comprising the same
US768306314 Jun 200423 Mar 2010Purdue Pharma L.P.Therapeutic agents useful for treating pain
US769620831 Jan 200613 Apr 2010Purdue Pharma L.P.Therapeutic agents useful for treating pain
US77003412 Feb 200120 Apr 2010Dendreon CorporationNucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
US772802528 Dec 20041 Jun 2010Banyu Pharmaceutical Co., Ltd.2-heteroaryl-substituted benzimidazole derivative
US775472328 Jun 200613 Jul 2010Therapeutic agents useful for treating pain
US77674295 Mar 20043 Aug 2010Halozyme, Inc.Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
US776769922 Dec 20053 Aug 2010Purdue Pharma, L.P.Therapeutic agents useful for treating pain
US777220627 Feb 200910 Aug 2010Genzyme CorporationMethods and compositions for the treatment of autoimmune disorders using clofarabine
US777225421 Mar 200610 Aug 2010Purdue Pharma L.P.Therapeutic agents useful for treating pain
US777686123 Jan 200617 Aug 2010Purdue Pharma L.P.Therapeutic agents useful for treating pain
US777690730 Oct 200317 Aug 2010Celgene CorporationMethods for the treatment and management of macular degeneration using cyclopropyl-N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide
US779090529 Dec 20037 Sep 2010McNeil-PPC, Inc.Pharmaceutical propylene glycol solvate compositions
US779980720 Mar 200621 Sep 2010Purdue Pharma L.P.Therapeutic agents useful for treating pain
US779982029 Sep 200621 Sep 2010Banyu Pharmaceutical Co., Ltd.2-Heterocycle-substituted indole derivatives for treating diabetes and associated conditions
US780336625 Aug 200828 Sep 2010NBTY, Inc.Methods and compositions that enhance bioavailability of coenzyme-Q10
US780378616 Jun 200528 Sep 2010Transform Pharmaceuticals, Inc.
University of South Florida
Pharmaceutical co-crystal compositions and related methods of use
US781216930 Nov 200112 Oct 2010The Children's Medical Center CorporationMethod of synthesis of 4-amino-thalidomide enantiomers
US78201996 Oct 200526 Oct 2010Schering CorporationStable extended release oral dosage composition
US78290814 Mar 20109 Nov 2010Halozyme, Inc.Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
US784269113 Apr 200330 Nov 2010Celgene CorporationMethod for the treatment of myelodysplastic syndromes using cyclopropanecarboxylic acid {2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-OXO-2,3-dihydro-1 H-isoindol-4-yl}-amide
US78464314 Mar 20107 Dec 2010Halozyme, Inc.Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
US785521715 Dec 200821 Dec 2010Celgene CorporationPolymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
US786329712 Nov 20074 Jan 2011Celgene CorporationMethods of using 4-(amino)-2-(2,6-dioxo(3-piperidly))-isoindoline-3-dione for the treatment of myelodysplastic syndromes
US787160723 Feb 200518 Jan 2011Halozyme, Inc.Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
US787984620 Sep 20071 Feb 2011Kyorin Pharmaceutical Co.., Ltd.Serine hydrolase inhibitors
US788348718 Dec 20088 Feb 2011Transdermal local anesthetic patch with injection port
US788809230 Oct 200915 Feb 2011Dendreon CorporationNucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
US78927765 May 200822 Feb 2011The Regents of the University of CaliforniaScreening assay to identify modulators of protein kinase A
US78930455 Aug 200822 Feb 2011Celgene CorporationMethods for treating lymphomas in certain patient populations and screening patients for said therapy
US790220830 May 20088 Mar 2011Schering CorporationTreating allergic and inflammatory conditions
US792761311 Sep 200319 Apr 2011University of South Florida
The Regents of the University of Michigan
Transform Pharmaceuticals, Inc.
Pharmaceutical co-crystal compositions
US79281326 Aug 200419 Apr 2011Ohio UniversityMethods for the amelioration of episodes of acute or chronic ulcerative colitis
US793191519 Nov 200826 Apr 2011Andrx Pharmaceuticals, LLCExtended release venlafaxine formulation
US793242112 Dec 200726 Apr 2011Amgen Inc.N-cyclohexyl benzamides and benzeneacetamides as inhibitors of 11-beta-hydroxysteroid dehydrogenases
US794368331 Oct 200717 May 2011Tepha, Inc.Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
US796460629 Jul 201021 Jun 2011Purdue Pharma L.P.Therapeutic agents useful for treating pain
US796856915 May 200328 Jun 2011Celgene CorporationMethods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
US797735723 Jul 200812 Jul 2011Celgene CorporationPolymorphic forms of 3-(4-amino-1-oxo-1, 3 dihydro-isoindo1-2-yl)-piperidine-2,6-dione
US799417721 Jul 20109 Aug 2011Purdue Pharma L.P.Therapeutic agents useful for treating pain
US80083008 Jul 200930 Aug 2011Purdue Pharma L.P.Therapeutic agents useful for treating pain
US801759816 May 200713 Sep 2011Knopp Neurosciences, Inc.Compositions of R(+) and S(−) pramipexole and methods of using the same
US802625410 Nov 200927 Sep 2011Purdue Pharma, L.P.Therapeutic agents useful for treating pain
US80303102 Mar 20104 Oct 2011Purdue Pharma, L.P.Therapeutic agents useful for treating pain
US803427030 Apr 200411 Oct 2011Tepha, Inc.Polyhydroxyalkanoate medical textiles and fibers
US805829224 May 201015 Nov 2011Purdue Pharma L.P.Therapeutic agents useful for treating pain
US805844315 Dec 200815 Nov 2011Celgene CorporationProcesses for preparing polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-YL))-piperidine-2,6-dione
US806322113 Mar 200722 Nov 2011Kyorin Pharmaceutical Co., Ltd.Aminoquinolones as GSK-3 inhibitors
US807159110 Mar 20106 Dec 2011Kyorin Pharmaceutical Co., Ltd.7-cycloalkylaminoquinolones as GSK-3 inhibitors
US807591120 Aug 200713 Dec 2011Alza CorporationTransparent transdermal nicotine delivery devices
US808405915 Sep 200627 Dec 2011ALZA CorporationAntidepressant dosage form
US808412511 Dec 200927 Dec 2011Tepha, Inc.Non-curling polyhydroxyalkanoate sutures
US810174515 Dec 200524 Jan 2012The Regents of the University of CaliforniaLung-targeted drugs
US810558615 Jun 201031 Jan 2012Halozyme, Inc.Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
US811060215 Jul 20097 Feb 2012Purdue Pharma L.P.Compounds comprising heterocyclic-substituted piperidine for treating pain
US812938810 Jun 20116 Mar 2012Purde Pharma L.P.Therapeutic agents useful for treating pain
US813820416 Jul 200720 Mar 2012ARYx Therapeutics, Inc.Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US813836127 Dec 200620 Mar 2012The Trustees Of The University Of Pennsylvania
Acidophil, LLC
C-10 carbamates of taxanes
US814328615 Dec 200827 Mar 2012Celgene CorporationPolymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione)
US815316227 Sep 200610 Apr 2012Tissuetech, Inc.Purified amniotic membrane compositions and methods of use
US815380616 Jul 201010 Apr 2012The Children's Medical Center CorporationSynthesis of 4-amino-thalidomide enantiomers
US816395716 Jul 201024 Apr 2012ProteoTech, Inc.Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease
US816863520 Jun 20051 May 2012Human BioMolecular Research InstituteModulators of central nervous system neurotransmitters
US81686722 Feb 20101 May 2012WyethThioamide derivatives as progesterone receptor modulators
US817856017 Jun 201015 May 2012Purdue Pharma L.P.Therapeutic agents useful for treating pain
US818284027 Sep 200622 May 2012Tissue Tech, Inc.Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
US818284127 Sep 200622 May 2012Tissue Tech, Inc.Amniotic membrane preparations and purified compositions and anti-inflammation methods
US818329020 Jul 201022 May 2012McNeil-PPC, Inc.Pharmaceutically acceptable propylene glycol solvate of naproxen
US818338110 Jul 200822 May 2012Metabolex Inc.N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
US81876302 Oct 200929 May 2012Schering-Plough CorporationExtended release oral dosage composition
US818763927 Sep 200629 May 2012Tissue Tech, Inc.Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
US818811819 Feb 200929 May 2012Celgene CorporationMethod for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with antibodies
US81932193 Oct 20115 Jun 2012Celgene CorporationPolymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
US819826219 Aug 200812 Jun 2012Celgene CorporationMethods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
US819830617 Dec 200912 Jun 2012Celgene CorporationMethods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a proteasome inhibitor
US820251720 Feb 200919 Jun 2012Halozyme, Inc.Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
US82029996 Jan 200619 Jun 2012Synta Pharmaceuticals Corp.Compounds for inflammation and immune-related uses
US82072008 May 200826 Jun 2012Celgene CorporationMethods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroindol-2-yl)-piperidine-2,6-dione follow by autologous stem cell transplantation
US82114285 Jul 20073 Jul 2012Torrey Pines Institute for Molecular Studies
Catalyst Biosciences, Inc.
Protease screening methods and proteases identified thereby
US821916813 Apr 200410 Jul 2012Abbott Diabetes Care Inc.Article and method for applying a coupling agent for a non-invasive optical probe
US822225730 Mar 200617 Jul 2012The Regents of the University of CaliforniaPhosphono-pent-2-en-1-yl nucleosides and analogs
US822746716 Feb 201024 Jul 2012Purdue Pharma L.P.Therapeutic agents useful for treating pain
US82274848 Mar 201224 Jul 2012Avanir Pharmaceuticals, Inc.Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
US82362886 Jan 20127 Aug 2012Skinmedica, Inc.Melanin modification compositions and methods of use
US824166221 Dec 200614 Aug 2012Watson Laboratories, Inc.Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy
USD42737015 Jun 199827 Jun 2000Avon Products, Inc.Nose strip
USRE3299125 Jul 198818 Jul 1989Thermedics, Inc.Drug dispensing wound dressing
USRE379343 Feb 200010 Dec 2002LTS Lohmann Therapie-Systeme AGTransdermal therapeutic system
USRE3958831 Oct 199024 Apr 2007Alza CorporationTransdermal drug delivery device
USRE4212630 Jun 20008 Feb 2011The Procter & Gamble CompanyDelivery system for oral care compositions comprising organosiloxane resins using a removable backing strip

Drawings